Delivery Order SPE2DX22D0020-SPE2D824F06PM
- Not listed
- This federal contract award, valued at $527,132.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and has no set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., also doing business as Amerisourcebergen. The...
- This federal contract award, valued at $895,373.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical...
- This federal contract award, valued at $674,900.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, and antibiotics. The...
- This federal contract award, valued at $574,193.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price, and no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This federal contract award, valued at $809,795.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling...
- This federal contract award, valued at $971,891.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is not a set-aside, is a delivery order contract for the supply of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $691,296.59, is a Firm Fixed Price Delivery Order for the supply of a range of pharmaceutical products and medical supplies to support military healthcare programs. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA,...
- This federal contract award, valued at $46,304.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, without any set-aside designation, indicating open competition. The contract provides for the delivery of a range of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology,...
- This federal contract award, valued at $967,033.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract does not have a set-aside...
- This federal contract award, valued at $724,354.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract does not have...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D824F06PMDelivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $876,316.77 and is structured as a delivery order with a firm fixed price. The contract does not have a set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) vehicle held by Amerisourcebergen's parent company, Cencora, Inc., also doing business as Amerisourcebergen. This IDC, valued at up to $999,999,999.00, provides a comprehensive global pharmaceutical support mechanism for the DLA Troop Support Medical through December 2026. Under this IDC, Amerisourcebergen supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard. The specific products being delivered under this contract include various prescription medications across therapeutic areas like diabetes, neurology, pain management, and other specialized treatments, as well as medical supplies. This contract award demonstrates Amerisourcebergen's capacity to efficiently fulfill diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $876.3k | 11/18/23 |